FDA Requests OMB Review for Proposed Information Collection on Orphan Drugs

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to orphan drugs, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.